Cell lines that differ by a single genetic change show promise in drug screens to identify compounds with gene-selective properties.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Torrance, C.J. et al. Nat. Biotechnol. 19, 940–945 (2001).
Huang, P.S. & Oliff A. Curr. Opin. Genet. Dev. 11, 104–110 (2001).
Gibbs, J.B. Science 287, 1969–1973 (2000).
Carpenter, C.L. & Cantley, L.C. Curr. Opin. Cell Biol. 8, 153–158 (1996).
Campbell, V.W. et al. Am. J. Med. Sci. 307, 167–172 (1994).
Koo, H.M., et al. Cancer Res. 59, 6057–6062 (2000).
Shirasawa, S. et al. Science 260, 85–88 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prendergast, G. Knockout drug screens. Nat Biotechnol 19, 919–920 (2001). https://doi.org/10.1038/nbt1001-919
Issue Date:
DOI: https://doi.org/10.1038/nbt1001-919